Hyphens Pharma Grants License for Cerapro® MED Skin Barrier Cream Across Six European Countries Hyphens Pharma has licensed its Cerapro® MED Skin Barrier Cream to Louis Widmer for distribution in six European countries, enhancing treatment options for atopic dermatitis.

Hyphens Pharma Grants License for Cerapro® MED Skin Barrier Cream Across Six European Countries #Singapore #Louis_Widmer #Hyphens_Pharma #Cerapro_MED

Hyphens Pharma Secures License for Cerapro® MED Cream Across Six European Nations Hyphens Pharma announces the licensing of its innovative cream, Cerapro® MED, for markets in six European countries. This product targets atopic dermatitis.

Hyphens Pharma Secures License for Cerapro® MED Cream Across Six European Nations #Singapore #Louis_Widmer #Hyphens_Pharma #Cerapro_MED

Hyphens Pharma Licenses Cerapro MED Skin Cream for Six European Markets Hyphens Pharma has entered a licensing agreement with Louis Widmer to market its Cerapro MED Skin Barrier Cream across six European countries, targeting atopic dermatitis.

Hyphens Pharma Licenses Cerapro MED Skin Cream for Six European Markets #Singapore #Louis_Widmer #Hyphens_Pharma #Cerapro

Hyphens Pharma Licenses Innovative Cerapro® MED Cream Across Europe Hyphens Pharma announces a licensing deal with Louis Widmer to commercialize Cerapro® MED Skin Barrier Cream in six European nations, enhancing treatment options for atopic dermatitis.

Hyphens Pharma Licenses Innovative Cerapro® MED Cream Across Europe #Singapore #Cerapro®_MED #Louis_Widmer #Hyphens_Pharma